|
| |
| | | 61137 | | 08.02.2011 | | Mepha Pharma AG | | | | | | | 07.02.2021 | | | | | | 11.09. | | 05.12.2018 | | 11.09. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Co-Dorzolamid-Mepha 2% / 0.5%.Augentropfen | | (Dorzolamide 20 mg/ml, Timolol 5 mg/ml) | S01ED51 | IPat | | 02 | Co-Dorzolamid Mepha | | (Dorzolamide 20 mg, Timolol 5 mg) | | |
|
|
|
